Medical Condition News

RSS

Study offers clues to potential treatments for preserving, restoring insulin-producing cells

In type 1 diabetes, the body relentlessly attacks and destroys its own insulin-producing pancreatic beta cells. But a study by Joslin Diabetes Center scientists now has firmly established that some of these cells endure for many decades in a small group of people with the disease—offering clues to potential treatments for preserving and even restoring the crucial cell population.

12 Aug 2010

Scientists awarded $348,037 to study causes, effects of hypoxia in Green Bay

Scientists researching the causes and effects of hypoxia in Green Bay, part of Lake Michigan, Wisc., have been awarded $348,037 for the first year of an anticipated four-year $1,367,300 project through NOAA's Coastal Hypoxia Research Program. Hypoxia within Green Bay has been a problem for decades, and recent evidence suggests that it may be worsening, with the potential for "dead zones" and fish kills to become both more frequent and more extensive with a changing climate.

12 Aug 2010

FDA advisory committee votes in favor of Ezogabine

The U.S. Food and Drug Administration advisory committee voted unanimously that clinical studies had provided substantial evidence of the effectiveness of Ezogabine (known as Retigabine outside of the U.S.) as adjunctive treatment for adults with partial-onset seizures.

12 Aug 2010

NYBC calls for blood donations

New York Blood Center, serving more than 20 million people in New York City, Long Island, the Hudson Valley, New Jersey, and parts of Connecticut and Pennsylvania, calls upon the communities it serves to remember your neighbors during this slow, late summer period for blood donations – and schedule a donation appointment or consider sponsoring a blood drive, because patients' needs do not take a summer break.

12 Aug 2010

Pelleve Wrinkle Reduction System launched across U.S.

Pelleve, the revolutionary skin tightening system for nonablative skin rejuvenation, is now available through dermatologists, plastic surgeons, medspas and cosmetic surgery clinics across the country.

12 Aug 2010

AVEO achieves enrollment target for tivozanib global Phase 3 clinical trial in advanced renal cell carcinoma

AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that it has achieved its enrollment target for TIVO-1, its global Phase 3 clinical trial for its oral, triple VEGF receptor inhibitor, tivozanib, in patients with advanced renal cell carcinoma. In February of this year, AVEO initiated enrollment in TIVO-1, and has successfully reached the target enrollment of 500 patients.

12 Aug 2010

Eastern Pennsylvania Sudden Cardiac Arrest Association launches response team with Amish community

Underscoring that a sudden cardiac arrest emergency requires quick response and that automated external defibrillators are easy to use, the Eastern Pennsylvania Chapter of the Sudden Cardiac Arrest Association has launched a unique community response team with the Amish community of Lancaster County, Pennsylvania, at the center of a broad program that will deploy AEDs in public locations, schools and even on horse and buggies and Amish farms to protect the community's residents and visitors from the nation's leading cause of death.

12 Aug 2010

NAMI calls for $20 billion relief fund to cover mental health needs resulting from oil spill

The National Alliance on Mental Illness has called on Kenneth Feinberg, the independent claims administrator for the $20 billion relief fund created by BP Oil Company, to cover mental health needs resulting from the company's massive oil spill in the Gulf of Mexico.

12 Aug 2010

Researchers suggest Hsp70 can reverse Diabetic peripheral neuropathy

Researchers have been able to use a common chaperone protein, Hsp70, to reverse the loss of function in the nerves of mice with diabetes.Writing in ASN NEURO, Michael J. Urban and colleagues at the University of Kansas suggest that Hsp70 could be used in the future to cure the loss of feeling in the limbs that afflicts many diabetics.

12 Aug 2010

Pathway's drug development milestone triggers $4.5M tranche of Series A private equity placement

Pathway Therapeutics, a drug discovery and development company founded in New Zealand, announced that it has met an important drug development milestone triggering a US$4.5 million fourth tranche of its Series A private equity placement. The financing was led by GBS Venture Partners, Australia and CM Capital Investments, Australia with co-investors the Breast Cancer Research Trust, the Trans-Tasman Commercialisation Fund, and the New Zealand Venture Investment Firm.

12 Aug 2010

25% of stroke patients stop taking prevention medication within 3 months

At least a quarter of patients who have suffered a stroke stop taking one or more of their prescribed stroke prevention medications within the first three months after being hospitalized - when the chance of having another stroke is highest - according to a new study by researchers at Wake Forest University Baptist Medical Center and colleagues.

12 Aug 2010

Early administration of TXA reduces death from bleeding without increase in complications: Study

If recently injured patients with serious bleeding were to receive a cheap, widely available and easily administered drug to help their blood to clot, tens of thousands of lives could be saved every year, according to a paper published on-line today by The Lancet.

12 Aug 2010

Ultrafine particle exposure may contribute to coronary heart disease risk in firefighters: Research

Exposure to high levels of ultrafine particles—invisible particles that can reach the smallest air passages in the lungs—may be an important contributor to the risk of coronary heart disease in firefighters, reports a study in the August Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine (ACOEM).

12 Aug 2010

LCA launches “National Shine a Light on Lung Cancer Vigil” to raise awareness

Today, Lung Cancer Alliance (LCA) announced the launch of the National Shine a Light on Lung Cancer Vigil to honor loved ones, raise awareness and provide hope, compassion and support for all those touched by lung cancer.

12 Aug 2010

Numerate collaborates with Intellikine to identify drug-like inhibitors of PI3 kinase alpha

Numerate, Inc. and Intellikine, Inc. today announced the successful conclusion of their research collaboration to discover novel small molecule compounds targeting the PI3K/mTOR signaling pathway. The collaboration combined Intellikine's unique capabilities in x-ray crystal structure-guided medicinal chemistry and drug discovery with Numerate's powerful computational drug design platform to identify potent, selective and drug-like inhibitors of PI3 kinase alpha, an important target in cancer therapy.

12 Aug 2010

Notre Dame, Madison Center collaborate to research on mental health therapies

Daniel Lapsley, Ph.D., Chairman of the Department of Psychology for Notre Dame University, gives a significant amount of credit to Madison Center, Indiana's largest community mental health agency, for Notre Dame's coup in recruiting two world-class researchers. Now Notre Dame and Madison Center have created a partnership to collaborate on research that is designed to improve treatment and therapies for mental health patients.

12 Aug 2010

Whiplash causes anatomical changes leading to brain injury: Study

While it has long been known that whiplash can cause injuries to the cervical spine, a new study published in the July issue of the journal Brain Injury, shows that whiplash may also cause anatomical changes that can result in brain injury.

12 Aug 2010

Study shows change in training can reduce ACL tears in female athletes

Anterior cruciate ligament injuries are a common and debilitating problem, especially for female athletes. A new study from UC Davis shows that changes in training can reduce shear forces on knee joints and could help cut the risk of developing ACL tears. The research was published online Aug. 3 in the Journal of Biomechanics.

12 Aug 2010

Reduced quality or quantity of sleep leads to school performance difficulties, behavior problems

Getting a good night's sleep often comes down to technique. Avoiding late-night technology use and keeping a regular sleep schedule are two important techniques to heed as kids head back to school.Recent studies found that adolescents used multiple forms of technology late into the night, including gaming systems, cell phones, and computers. As a result, they demonstrated difficulty staying awake and alert throughout the day.

12 Aug 2010

Pulse Therapeutics receives fund to develop novel magnetics technique to destroy blood clots

BioGenerator, a non-profit, seed-stage economic development funding group, today announced that it has led a round of early-stage financing for Pulse Therapeutics, Inc., a St. Louis company headquartered at the Center for Emerging Technologies. Pulse Therapeutics develops innovative magnetism-based technology to safely destroy blood clots related to ischemic stroke and deep vein thrombosis (DVT). Other investors who participated in the round were Missouri Technology Corporation (MTC), Washington University's Olin School of Business Skandalaris Student Venture Fund, and Integrated Magnetics, of Culver City, California. The funds will be used for further pre-clinical development.

12 Aug 2010

Medical Condition News

Study offers clues to potential treatments for preserving, restoring insulin-producing cells

Scientists awarded $348,037 to study causes, effects of hypoxia in Green Bay

FDA advisory committee votes in favor of Ezogabine

NYBC calls for blood donations

Pelleve Wrinkle Reduction System launched across U.S.

AVEO achieves enrollment target for tivozanib global Phase 3 clinical trial in advanced renal cell carcinoma

Eastern Pennsylvania Sudden Cardiac Arrest Association launches response team with Amish community

NAMI calls for $20 billion relief fund to cover mental health needs resulting from oil spill

Researchers suggest Hsp70 can reverse Diabetic peripheral neuropathy

Pathway's drug development milestone triggers $4.5M tranche of Series A private equity placement

25% of stroke patients stop taking prevention medication within 3 months

Early administration of TXA reduces death from bleeding without increase in complications: Study

Ultrafine particle exposure may contribute to coronary heart disease risk in firefighters: Research

LCA launches “National Shine a Light on Lung Cancer Vigil” to raise awareness

Numerate collaborates with Intellikine to identify drug-like inhibitors of PI3 kinase alpha

Notre Dame, Madison Center collaborate to research on mental health therapies

Whiplash causes anatomical changes leading to brain injury: Study

Study shows change in training can reduce ACL tears in female athletes

Reduced quality or quantity of sleep leads to school performance difficulties, behavior problems

Pulse Therapeutics receives fund to develop novel magnetics technique to destroy blood clots

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Latest News